BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34565105)

  • 1. Histone deacetylase inhibitor, mocetinostat, regulates cardiac remodelling and renin-angiotensin system activity in rats with transverse aortic constriction-induced pressure overload cardiac hypertrophy.
    Kim GJ; Jung H; Lee E; Chung SW
    Rev Cardiovasc Med; 2021 Sep; 22(3):1037-1045. PubMed ID: 34565105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy.
    Jung H; Lee E; Kim I; Song JH; Kim GJ
    Physiol Res; 2019 Oct; 68(5):727-737. PubMed ID: 31424255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase Inhibition Attenuates Aortic Remodeling in Rats under Pressure Overload.
    Jung H; Lee E; Kim I; Kim GJ
    Biomed Res Int; 2020; 2020():4705615. PubMed ID: 32775424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
    Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
    Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
    Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
    Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1.
    Zhao T; Kee HJ; Kee SJ; Jeong MH
    Oxid Med Cell Longev; 2022; 2022():6227330. PubMed ID: 35126818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice.
    Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
    Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
    Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.
    Sun S; Kee HJ; Jin L; Ryu Y; Choi SY; Kim GR; Jeong MH
    J Cell Mol Med; 2018 Dec; 22(12):5964-5977. PubMed ID: 30256522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentianella acuta improves TAC-induced cardiac remodelling by regulating the Notch and PI3K/Akt/FOXO1/3 pathways.
    Zhou WW; Dai C; Liu WZ; Zhang C; Zhang Y; Yang GS; Guo QH; Li S; Yang HX; Li AY
    Biomed Pharmacother; 2022 Oct; 154():113564. PubMed ID: 35988427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of isosteviol sodium on cardiac function and myocardial remodelling in transverse aortic constriction rat.
    Ke Q; Liu F; Tang Y; Chen J; Hu H; Sun X; Tan W
    J Cell Mol Med; 2021 Jan; 25(2):1166-1177. PubMed ID: 33336505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload.
    Liu Q; Lu D; Wang S; Wang K; Zhang Q; Wang Y; Fang P; Li Z; Geng J; Shan Q
    J Am Soc Hypertens; 2016 Jul; 10(7):587-596.e4. PubMed ID: 27288113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.